BIOTECH FUNDING TRENDS
商品資訊
ISBN13:9783527324354
出版社:JOHN WILEY & SONS;LTD
作者:GRUBER
出版日:2009/01/14
裝訂/頁數:精裝/210頁
定價
:NT$ 6748 元優惠價
:90 折 6073 元
若需訂購本書,請電洽客服 02-25006600[分機130、131]。
商品簡介
作者簡介
名人/編輯推薦
目次
相關商品
商品簡介
Based on interviews with dedicated biotech entrepreneurs and high-level investors as well as case studies, this title provides a comprehensive overview of current trends in biotech funding.
In particular, it illustrates the tensions between both sides based on their different backgrounds and expectations. The book outlines the various funding opportunities for the biotech industry in Europe and identifies ways for both sides to overcome their existing prejudices in order to successfully thrive in a competitive environment.
A must-have for biotech entrepreneurs and investors, as well as invaluable supplementary reading for students aspiring to a career in the industry.
In particular, it illustrates the tensions between both sides based on their different backgrounds and expectations. The book outlines the various funding opportunities for the biotech industry in Europe and identifies ways for both sides to overcome their existing prejudices in order to successfully thrive in a competitive environment.
A must-have for biotech entrepreneurs and investors, as well as invaluable supplementary reading for students aspiring to a career in the industry.
作者簡介
Alexandra Carina Gruber, born in 1971 in Vienna, Austria, graduated in pharmacy from the University in Vienna in 1997 and has been working in the pharmaceutical industry for the past 12 years, where she has held various marketing and business development positions and developed a profound expertise in the marketing and licensing of biotech and generic products. During her professional career she committed herself to an Executive MBA study course from the University of Business Administration and Economics in Vienna together with the University of Minnesota as well as a postgraduate education in Finance at the Danube University Krems together with the University of British Columbia, Vancouver. For more information, please go to www.acgruber.eu
名人/編輯推薦
"Gruber has become a veteran of marketing and business development in the pharmaceutical industry around the world, specializing in marketing and licensing biotechnological and generic products. She conducted qualitative interviews with entrepreneurs, venture capitalists, and other investors about the interpersonal and financial aspects of starting a biotech company, and presents the results here. By describing the characteristics beliefs, and expectations of each of the groups, she hopes to help investors and entrepreneurs build relationships based on mutual understanding that will lead to greater success in the biotech business, and most especially European companies in competition with American ones." (SciTech Book News, December 2010)
目次
Preface.
Acknowledgments.
Limit of Liability/Disclaimer of Warranty.
Executive Summary.
1. Introduction.
1.1 Development of the Private Equity and Venture Capital Market.
1.2 Development of the Biotech Industry.
2. Methodology.
2.1 Formulating the Research Goal.
2.2 Conducting the Study.
2.3 Evaluating the Results.
3. Data Analysis and Interpretation of Results.
3.1 Description of Interview Partners.
3.2 Major Characteristics of an Entrepreneur.
3.3 Major Characteristics of a Venture Capitalist.
3.4 The Most Important Partnering Criteria.
3.5 Financing Models.
3.6 Biotech Research Areas.
3.7 Alliances and Funding in the Early Stage.
3.8 Alliances and Funding in the Late Stage.
3.9 Exit Routes.
3.10 Primary Causes of Failure.
3.11 Best-practice Countries for Funding Biotech Start-ups.
3.12 Most Striking Differences between the US and European Venture Capital Markets.
4. Biotech Case Studies.
4.1 AUSTRIANOVA Biomanufacturing AG.
4.2 AVIR Green Hills Biotechnology AG.
4.3 EUCODIS GmbH
4.4 Intercell AG.
4.5 onepharm Research & Development GmbH.
5. Summary and Conclusions.
5.1 The Challenge: When Science Meets Business.
5.2 Checklists.
5.3 Final Observations.
6. Outlook and Recommendations.
Epilogue.
References.
Appendix A: List of Abbreviations.
Appendix B: Glossary.
Appendix C.
Appendix D: Questionnaires.
Index.
Acknowledgments.
Limit of Liability/Disclaimer of Warranty.
Executive Summary.
1. Introduction.
1.1 Development of the Private Equity and Venture Capital Market.
1.2 Development of the Biotech Industry.
2. Methodology.
2.1 Formulating the Research Goal.
2.2 Conducting the Study.
2.3 Evaluating the Results.
3. Data Analysis and Interpretation of Results.
3.1 Description of Interview Partners.
3.2 Major Characteristics of an Entrepreneur.
3.3 Major Characteristics of a Venture Capitalist.
3.4 The Most Important Partnering Criteria.
3.5 Financing Models.
3.6 Biotech Research Areas.
3.7 Alliances and Funding in the Early Stage.
3.8 Alliances and Funding in the Late Stage.
3.9 Exit Routes.
3.10 Primary Causes of Failure.
3.11 Best-practice Countries for Funding Biotech Start-ups.
3.12 Most Striking Differences between the US and European Venture Capital Markets.
4. Biotech Case Studies.
4.1 AUSTRIANOVA Biomanufacturing AG.
4.2 AVIR Green Hills Biotechnology AG.
4.3 EUCODIS GmbH
4.4 Intercell AG.
4.5 onepharm Research & Development GmbH.
5. Summary and Conclusions.
5.1 The Challenge: When Science Meets Business.
5.2 Checklists.
5.3 Final Observations.
6. Outlook and Recommendations.
Epilogue.
References.
Appendix A: List of Abbreviations.
Appendix B: Glossary.
Appendix C.
Appendix D: Questionnaires.
Index.
主題書展
更多
主題書展
更多書展今日66折
您曾經瀏覽過的商品
購物須知
外文書商品之書封,為出版社提供之樣本。實際出貨商品,以出版社所提供之現有版本為主。部份書籍,因出版社供應狀況特殊,匯率將依實際狀況做調整。
無庫存之商品,在您完成訂單程序之後,將以空運的方式為你下單調貨。為了縮短等待的時間,建議您將外文書與其他商品分開下單,以獲得最快的取貨速度,平均調貨時間為1~2個月。
為了保護您的權益,「三民網路書店」提供會員七日商品鑑賞期(收到商品為起始日)。
若要辦理退貨,請在商品鑑賞期內寄回,且商品必須是全新狀態與完整包裝(商品、附件、發票、隨貨贈品等)否則恕不接受退貨。